Ionis Pharmaceuticals, Inc. (IONS) — Dilution Risk Analysis

Current Snapshot

Ionis Pharmaceuticals, Inc. (IONS) has a DilutionWatch score of 18/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
166,184,322 Source
Public Float
163,978,466 Source
Float as % of Outstanding
98.7%

Dilution Risk Score

Score: 18/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: XBRL 1, 4 9.

FormFiledAccession
xbrl 2026-06-30 xbrl-639-xbrl_convertible
4 2026-04-17 0000874015-26-000169
4 2026-04-17 0000874015-26-000170
4 2026-04-17 0000874015-26-000171
4 2026-04-17 0000874015-26-000172
4 2026-04-02 0000874015-26-000160
4 2026-04-02 0000874015-26-000161
4 2026-03-23 0000874015-26-000152
4 2026-03-18 0000874015-26-000146
4 2026-03-11 0000874015-26-000142

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 20 months Source
Three-year share count growth 15.83% Source

DilutionWatch Analysis

Risk Level
LOW (Score: 18/10) Source
Cash Runway
20 months Source
Share Count Growth (3-Year)
15.83% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.